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Abstract
An efficient entry to the preparation of elusive 4-unsubstituted-3-iodo-2H-chromenes has been accomplished as result of a catalytic
cyclization. Thus, upon exposition of [(3-iodoprop-2-yn-1-yl)oxy]arenes to IPrAuNTf2 (3 mol %), in 1,4-dioxane at 100 °C, the
desired heterocyclic motif is readily assembled. This process nicely tolerates a variety of functional groups and, interestingly, it is
compatible with the presence of strong electron-withdrawing groups attached to the arene. The overall transformation can be termed
as a new example of a migratory cycloisomerization and, formally, it involves well-blended 1,2-iodine shift and hydroarylation
steps.
Introduction
The structure of 2H-chromene embodies a relevant heterocyclic
motif, which is present in naturally occurring compounds [1-6]
and encodes interesting properties that renders it attractive
for functional applications. Thus, for instance, this molecular
frame has been associated with photochromic crystals [7],
photochromic organogelators [8], selective cyclooxygenase-2
inhibitors [9,10], antifungal [11] and antitrypanocidal activity
[12], transforming growth factor-β receptors [13] and with
potential novel termiticides [14], among other remarkable appli-
cations. On this basis, new approaches to access this relevant
heterocyclic scaffold are the subject of ongoing synthetic
interest [15-22].
In connection with synthetic efforts searching for new Hsp90
inhibitors [23], the metal-catalyzed coupling reaction of
nitrogen-containing nucleophiles with 3-halo-substituted
chromenes has been recognized as a convenient synthetic tool,
which provides smooth access to potentially useful candidates
[24]. The required halogen containing building-blocks can be
prepared from aryl propargyl ethers following either metal-free
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iodinating [25,26] or a palladium-catalyzed brominating [27]
approach that yield the required halogenated regioisomer at the
time of assembling the target heterocyclic skeleton. These
strategies are quite general to give 3-halo-4-substituted-2H-
chromenes (see Scheme 1, entries a and b, respectively).
However, they fail to produce simple 3-halo-4-unsubstituted
derivatives. This synthetic context suggests a timely opportu-
nity for devising new protocols to access the latter class
of 3-halo-2H-chromene scaffolds from readily available
precursors. Although a stepwise selective modification of the
preassembled heterocycle has been recently developed
(Scheme 1 entry c) [28], a de novo elaboration of 3-halo-2H-
chromenes giving straight access to the desired regioisomer is
yet to be accomplished. A desirable approach would also
consider the generation of an increase in the molecular diver-
sity, offering a suitable strategy intended for library discovery.
Scheme 1: Synthesis of 3-halo-2H-chromenes.
It is well known that metal-catalyzed hydroarylation is a power-
ful reaction to prepare benzofused heterocyclic compounds [29-
31]. Pt(IV) [32], Pt(II) and Au(I) [33] complexes were early
recognized as suitable catalysts to convert aryl propargyl ethers
into chromenes. Nowadays, alternative gold(I)-based catalysts
have been successfully exploited to further prepare substituted
2H-chromenes [34-38], as well as a wide variety of relevant
heterocyclic compounds [39,40].
On the other hand, migratory cycloisomerization are important
processes in contemporary catalysis [41]. In this context, our
group is interested in C–H functionalization reactions of arenes
involving propargylic derivatives [42]. Furthermore, the influ-
ence of different gold(I) catalysts over the outcome of the
cyclization of N-(3-iodoprop-2-ynyl)-N-tosylanilines has been
noticed [43]. For the latter reaction, conditions to modulate the
relative amount of each of the possible regioisomeric cycliza-
tion products formed, with or without iodine shift, were
outlined. Tuning the ligand at the gold atom [44] was used to
accomplish a reaction manifold earlier recognized in the syn-
thesis of regioisomeric halogenated phenanthrenes, but they are
using two different metals [45]. Catalytic cycloisomerization
reactions of heteroatom-substituted alkynes that take place
without heteroatom migration are known [46-48].
On this ground, we were curious about the attractive possibility
of combining known reaction profiles in an attempt to execute
an efficient entry into the elusive 4-unsubstituted-3-iodo-2H-
chromene derivatives. We hypothesize that this specific hetero-
cyclic motif can be conveniently prepared from cyclization of
aryl (3-iodoprop-2-yn-1-yl) ethers relying on the power of
gold(I) catalysis, as depicted in Scheme 1 entry d. Herein, we
report a new strategy to carry out this transformation.
Results and Discussion
In a previous work on gold-catalyzed cyclization reactions of
N-(3-iodoprop-2-ynyl)-N-tosylanilines, the influence of the
ancillary ligand and the arene over the cyclization products was
recognized [43]. The catalyst based on the N-heterocyclic
carbene ligand IPr [49] (IPr: 1,3-bis(2,6-diisopropyl)phenyl-
imidazol-2-ylidene), was identified as suitable controller to
favor the formation of the product arising from the migratory
cyclization against that deriving from a straight iodoalkyne
arylation reaction. As for the substituents on the amine
ring, more electron-donating ones gave rise to the formation
of the heterocycle featuring a distribution of regioisomers
that indicates less iodine shift. In this context, switching
from NTs to O as the linker is, intrinsically, a demanding
process attempting to access 3-iodo-2H-chromene cores,
as migration is less favorable for more electron-donating
groups. So, the application of this cyclization and concomitant
iodine migration strategy to synthesize the target chromenes is
challenging.
On this basis, we started to investigate the feasibility of the
intended synthetic approach to the target chromene scaffold
exploring the reactivity of 1-chloro-4-[(3-iodoprop-2-yn-1-
yl)oxy]benzene (1a) as model compound. For the catalyst,
the gold(I) complex with the IPr ligand was systematically
tested. As for the counter anion to gold, bis(trifluoromethane-
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Table 1: Screening for conditions for the hydroarylation of 4-chlorophenyl (3-iodoprop-2-yn-1-yl) ether.
Entry Solvent T (°C) t (h) % conversiona 2a:3a
1 ClCH2CH2Cl rt 14 70 2:1
2 Et2O rt 24 34 4.3:1
3 Et2O 40 24 62 4.5:1
4 t-BuOMe 56 24 – –
5 dioxane rt 24 40 5.2:1
6 dioxane 40 24 68 5.3:1
7 dioxane 100 2.25 98 5:1
8 CH3NO2 rt 24 – –
9 CH3NO2 40 24 71 2.3:1
10 DMSO 80 24 – –
11 DMF 80 24 – –
12 ClCH2CH2Cl/CH3CN
(1:1)
80 24 – –
aConversion determined by NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard.
sulfonyl)imidate (NTf2) was chosen which, as early pointed out
by Gagosz, renders very active catalysts [50].
An initial screening for experimental conditions showed that
heating the reaction mixture at 100 °C in 1,4-dioxane provides a
good result for the synthesis of the desired 6-chloro-3-iodo-2H-
chromene (2a), using 3 mol % of IPrAuNTf2 as catalyst.
Representative data concerning the selection of the solvent and
the identification of convenient values for the reaction tempera-
ture and time are summarized in Table 1.
For the solvent, weakly coordinating polar ethers offer a fair
balance for conversion and regioselectivity. In this regard, reac-
tion in 1,4-dioxane at 100 ºC were identified as the best experi-
mental conditions to approach the cyclization leading to the
desired 3-iodochromene 2a. Thus, the conditions outlined in
Table 1 entry 7 were chosen to broach the potential of this 1,2-
iodine migration–hydroarylation process using different iodi-
nated propargyl aryl ethers. The results are summarized in
Table 2.
Interestingly, as no further additives are required, heating the
corresponding aryl propargyl ether in dioxane under the sole
influence of a relatively low catalyst loading furnishes, consis-
tently, a significant variety of differently substituted chromenes.
The selectivity in favor of the 3-iodo-substituted chromene is in
all cases of practical significance. In some cases, exclusive for-
mation of the desired 3-iodo-2H-chromene is noticed upon
inspection of the crude reaction mixture; see, for instance,
Table 2 entries 5 and 8. The structure of the prepared com-
pounds 2 was established from their characterization data (see
Supporting Information File 1). The recorded data nicely
endorse the assigned structure, which was further corroborated
by an X-ray analysis of 2f (Figure 1).
Figure 1: X-ray molecular structure of 2f.
The assembled collection of 4-unsubstituted iodinated hetero-
cycles is relevant, both in terms of functional group tolerance
and also for the purpose of further molecular diversification.
A gram-scale reaction was conducted on the multi-halogen-
containing precursor 1f. The process is robust and 8-chloro-6-
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Table 2: Synthesis of 3-iodo-2H-chromenes.
Entry 1 t (h) Yield (%)a 2:3b 2
1
1b
3 91 14:1
2b
2
1c
3 87 11:1
2c
3
1d
3 97 6:1
2d
4
1e
5 88 17:1
2e
5
1f
5 90 1:0
2f
6
1g
3 96 8:1
2g
(p:o = 3:1)
7
1h
3 89 5:1
2h
8
1i
3 93 1:0
2i
aIsolated yield (mixture of regioisomers). bDetermined from the crude of reaction.
fluoro-3-iodo-2H-chromene (2f) was readily obtained (1.5 g,
97% yield) after purification by column chromatography from
the reaction of 5 mmol of 1f (1.55 g) (Scheme 2).
Also, another practical issue that was addressed was the proof
of the configurational stability of a chiral center in the vicinity
of the alkyne. For this purpose, optically active 1j was prepared.
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Scheme 3: Retaining propargylic chirality.
Scheme 4: Mechanistic basis postulated for the synthesis of 2.
Scheme 2: Gram-scale synthesis of 2f.
As next step, its reactivity in the gold(I)-catalyzed hydroaryl-
ation study was investigated (Scheme 3).
Though the regioselectivity was lower and requires further opti-
mization, this experiment nicely reveals that chirality installed
at the propargylic position in the starting material can be
successfully delivered to the cyclization product, as the result of
this hydroarylation with concomitant 1,2-iodine shift process.
Although this work deals mainly with preparative aspects for
the title compounds, a preliminary mechanistic proposal to
justify the obtained results could reasonably involve the genera-
tion of gold–vinylidene B as key intermediate behind the forma-
tion of the corresponding 3-iodo-2H-chromenes 2 (X = O,
Scheme 4A).
Gold–vinylidenes have been proposed to mediate related hydro-
arylation reactions affording halogenated phenanthrenes [45]
and 3-iodo-N-tosyl-1,2-dihydroquinoline derivatives [43].
Recent studies have provided strong evidence for their exis-
tence, and have demonstrated their powerful reactivity [51-55],
identifying them as key players in ongoing activity developing
the exciting notion of dual activation using gold catalysts [56].
As outlined in Scheme 4A, after an initial π-activation of the
iodoalkyne, gold might trigger the generation of the β-iodo-
substituted vinylidene B, in a process that might take place in
competition with a direct Friedel–Crafts-type cyclization reac-
tion yielding 3. In previous work dealing with the cyclization of
N-(3-iodoprop-2-ynyl)-N-tosylanilines to give related 1,2-dihy-
droquinolines (Scheme 4A, X = NTs) [43], we documented for
a phosphite-based gold-catalyst, which render a more electro-
philic metal center, an increase of the relative amount of the
Beilstein J. Org. Chem. 2013, 9, 2120–2128.
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cyclization product 3 (4-iodo-substituted, X = NTs) at the
expenses of the formation of the one with concomitant iodine
shift, product 2 (3-iodo-substituted, X = NTs). On the contrary,
under related conditions, a gold catalyst based on the electron-
rich and neutral donor IPr ligand favors the latter cyclization
against the former.
On this ground, a change in the tethering element switching the
linker from NTs to oxygen (Scheme 4A, X = O) results in more
activated rings towards aromatic electrophilic substitution
processes. To this respect, two facts are of mechanistic signifi-
cance. First, the 2:3 ratio for a given R substituent (Scheme 4A,
R = 4-Cl) can be compared for the two linkers. For the nitrogen-
containing tether (X = NTs, Scheme 4A), almost exclusive for-
mation of 2 was noticed (reaction in 1,2-dichloroethane, at rt for
24 h, [43]). However, for the case of X = O, the corresponding
value for the 2:3 ratio is 5:1 (Table 1, entry 7). Next, as depicted
in Table 2, the herein reported cyclization takes place satisfacto-
rily when additional electron-withdrawing groups are attached
to the aromatic ring, the yield typically ranging on or above the
nineties. At the same time, the selectivity of the process is
dependent on the nature of the substituent R in Scheme 4A.
Remarkably, the more electron-withdrawing group (R = NO2,
Table 2, entry 4) gives similar yield and higher 2:3 ratio than
the aldehyde (R = CHO, Table 2 entry 2). For less electron-
withdrawing substituents such as halogens an increase in selec-
tivity was noticed as function of their number and nature. This
is shown for the cyclization of 1a (Table 1, entry 7) in compari-
son with the cyclization of 1f and 1i (Table 2, entries 5 and 8).
These results nicely match the proposed process competition
scenario. The noticed scope endorses an active involvement for
a highly reactive gold–vinylidene intermediate as responsible
for the selectivity of the eventual cyclization step, in agreement
with the tentative mechanistic rationale depicted in Scheme 4A.
Though the substitution pattern is not the one commonly asso-
ciated with conventional electrophilic aromatic substitution
reactions, other mechanism should not be disregarded on the
basis of the structure of the final product. So, the alternative
mechanistic description summarized in Scheme 4B cannot be
firmly rejected, at the moment. In this case, a demanding elec-
trophilic substitution must occur and should produce very effi-
ciently the 3-aurated-4-iodo-2H-chromene C and one equiva-
lent of acid. Next, gold-assisted protonation at C-4 should
afford D [57], an intermediate featuring a gold-carbene at C-3,
that would require a subsequent and selective 1,2-iodine shift to
furnish compounds 2 and regenerate the catalyst.
In this context, on the basis of the information gathered so far,
and taking into account the precedents in the literature, we favor
the mechanism outlined in Scheme 4A as the most likely one.
Conclusion
In short, the reported gold-catalyzed cyclization opens up a
versatile approach to the synthesis of elusive 4-unsubstituted-3-
iodo-2H-chromenes. This transformation uses common starting
materials. The resulting protocol is compatible with a signifi-
cant variety of functional groups and can be easily conducted on
a gram-scale.
Experimental
All the reactions were carried out using oven dried glassware
under nitrogen (99,99%) or argon (99,999%) atmosphere.
Dioxane was distilled before used from sodium. Flash chroma-
tography was performed on silica gel 60 (230–400) mesh. The
solvents used in flash chromatography, hexane and ethyl
acetate, were obtained from commercial suppliers and used
without further purification. Cyclization reactions were
performed in a RR98030 12 place Carousel Reaction StationTM
from Radleys Discovery Technologies, equipped with gas-tight
threaded caps with a valve, cooling reflux head system, and
digital temperature controller. All common reagents and
solvents were obtained from commercial suppliers and used
without any further purification unless otherwise noted.
1H NMR (300, 400 MHz) and 13C NMR (75.5, 100 MHz)
spectra were measured in CDCl3, CD2Cl2 or DMSO at room
temperature on a Bruker DPX-300, or Bruker AVANCE-300
MHz and 400 MHz instruments, with CHCl3 (δ = 7.26,
1H NMR; δ = 77.16, 13C NMR), CH2Cl2 (δ = 5.33, 1H NMR;
δ = 54.84, 13C NMR) or DMSO (δ = 2.50, 1H NMR; δ = 39.52,
13C NMR) as internal standards. Data are reported as follows:
chemical shift, multiplicity (s: singlet, bs: broad singlet,
d: doublet, t: triplet, q: quartet, m: multiplet), coupling constants
(J in Hz) and integration. Carbon multiplicities were assigned
by DEPT and HSQC techniques. Melting points (mp) were
measured on a Büchi–Totoli apparatus and are uncorrected.
Synthesis of starting materials
Starting materials 1 were obtained from the corresponding
phenols through a two steps synthetic route.
General procedure for the propargylation of phenols
To a suspension or solution of the corresponding phenol
(1 equiv; 5 mmol) in DMF (20 mL), potassium carbonate was
added (2 equiv; 10 mmol) followed by a solution of propargyl
bromide (commercial source: 80% in toluene) (1.5 equiv;
7.5 mmol). The reaction was controlled by TLC and when it
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was finished, it was diluted with Et2O (30 mL) and then brine
was added. The organic layer was washed in a separation funnel
with brine to extract all the DMF (5 times, 15 mL), dried over
Na2SO4, filtered and evaporated to afford the corresponding
crude mixture which, in most cases, was pure enough to use in
the next step without further purification.
Iodination of terminal alkynes
The starting alkyne (1 equiv; 2 mmol) was dissolved in acetone
(10 mL). Then, silver nitrate (0.1 equiv; 0.2 mmol) and
N-iodosuccinimide (NIS) (1.15 equiv; 2.30 mmol) were added
successively. After three hours, the reaction mixture was cooled
to 0 °C and filtered. The resulting crude was subjected to flash
chromatography to obtain compounds 1 substantially pure.
Preparation of ethers from phenols and chiral non-racemic
propargylic alcohols
(S)-(−)-3-butyn-2-ol (5 mmol; commercially available, 464007
Sigma-Aldrich) was dissolved in THF (25 mL) in a flame dried
round bottom flask, under nitrogen atmosphere, and the corres-
ponding phenol (1.05 equiv, 5.25 mmol) and triphenylphos-
phine (1.1 equiv, 5.5 mmol) are added successively. The solu-
tion was cooled to 0 °C and diethyl azodicarboxylate (1.2 equiv,
6 mmol) was added dropwise. The ice bath was removed and
the reaction was stirred overnight. The solvents were removed
under reduced pressure and the resulting crude was subjected to
flash chromatography to give substantially pure and optically
active terminal alkynes with (R)-configuration.
Cycloisomerization to give 3-iodo-2H-chromenes
To a solution of the corresponding starting material 1 (1 equiv;
0.3 mmol) in dioxane (2 mL), under argon atmosphere,
IPrAuNTf2 was added (0.03 equiv; 0.009 mmol) and the reac-
tion mixture was heated at 100 °C. The reaction progress was
monitored by TLC and, upon completion, solvents were
removed under vacuum and the resulting crude was subjected to
flash chromatography to afford the products (see specific condi-
tions for each substrate).
Scaled-up cycloisomerization of 2-chloro-4-fluoro-1-[(3-
iodoprop-2-yn-1-yl)oxy]benzene (1f)
5 mmol of 1f (1.55 g) were disposed in a flame-dried 250 mL
Schlenk flask under argon and dissolved with 35 mL of dry
dioxane. After complete solution of the starting material,
0.15 mmol of the catalyst (3 mol %; 0.130 g) were added and
the reaction was heated at 100 °C. After 5 h, when the reaction
was finished, solvents were removed in vacuum and the solid
residue was purified by flash chromatography using n-hexane as
eluent furnishing 2f with >99:1 regioselectivity (2:3) and in
97% yield (1.50 g).
Supporting Information
Supporting Information File 1
Characterization data for compounds 1a–j and 2a–j; 1H and
13C NMR spectra for compounds 1a–j and 2a–j; X-ray
molecular structure for 2f; HPLC chromatograms for 1j and
2j and structural assignment for compounds 3.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-9-249-S1.pdf]
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